The cerebellum is known as the major target regions of methylmercury (MeHg) toxicity, but the mechanisms are still not fully understood. We studied the effects of MeHg exposure in the cerebellum of common marmoset (Callithrix jacchus) using a shotgun proteomic approach with liquid chromatography coupled to mass spectrometry. A total of 1000 common proteins were identified in all samples, and 102 proteins were significantly differentially expressed in the cerebellum of common marmoset with orally dosed MeHg (1.5 mg MeHg/kg body weight for 2 weeks) compared with those of the control group. Functional enrichment analysis and pathway predictions showed that the differentially expressed proteins were involved in carbohydrate derivative metabolic process, ion transport including synaptic transmission, cell development, and calcium signaling pathway. Cellular component enrichment analysis showed that they were mainly distributed in plasma membrane, excitatory synapse, and synaptic membrane. These results indicate that synaptic transmission and calcium signaling pathways are the core functions affected by MeHg. We found a total of 21 novel proteins affected by MeHg in synaptic transmission and calcium signaling pathways. DLG4 (PSD95) and MIR-19A/MIR-19B were found to be potential key targets leading to the multiple effects of MeHg neurotoxicity. These results show the global effects of MeHg on cellular functions and pathways leading to neurological deficits in common marmoset.
Methylmercury (MeHg) is a widely known environmental neurotoxicant and the cerebellum is one of the major target regions against MeHg exposure (Clarkson and Magos, 2006) . The most well-known MeHg poisoning incident happened in Minamata, Japan in the 1950s where Minamata disease patients suffered from ataxia as a result of cerebellar dysfunction (Clarkson et al., 2003) . The central type of atrophy was observed in the vermis and its surrounding regions in cerebellum in prolonged cases of Minamata disease. Cerebellar impairments were featured by the loss of granule cells and relatively integrated purkinje cells (Takeuchi and Eto, 1999) . A large amount of mercury was found in the remaining nerve cells, glia cells, and phagocytes in the lesioned granular layer of Minamata disease cases (Okabe and Takeuchi, 1980) . Numerous experimental studies have been published on the molecular mechanisms of MeHg neurotoxicity (see Farina et al., 2011 for review) . However, most of these studies focused on the effects of MeHg on a specific mechanism or pathway, and very few studies report the systemic effects in the brain. Omics technologies such as proteomics provide a powerful tool to study cellular function in response to environmental stimulus at the biological level (Dowd, 2012) . In a recent proteomic study, Kong et al. (2013) found a deficit of metabolic status in rat somatosensory cortex with chronic exposure of MeHg (40 mg/kg/day).
Another proteomic study for MeHg toxicity reported that nonphosphorylated cofilin, an important protein to regulate actin dynamics, was significantly increased with 60 nM MeHg exposure for 10 days in primary culture of cerebellar granule neurons (Vendrell et al., 2010) . Rodents and primary cell cultures were used as tested models in these studies.
Nonhuman primates have a common ancestry to human being, and in many aspects they share many similarities with humans than rodents, such as neuroanatomy, intricacy of brain organization, and complex cognitive capabilities. Therefore, primates are regarded as the best model for the understanding of molecular mechanism for human particularly in neurodegenerative diseases (Capitanio and Emborg, 2008) . Common marmoset is one of the most utilized nonhuman primate species in biomedical research offering unique behavioral, neuroanatomical, and neurobiochemcial similarities to humans (Okano et al., 2012) . It has been reported that common marmosets are particularly appropriate model for MeHg neurotoxicity studies versus other primate models, as the pathological changes in target brain regions (cerebellum, cerebrum, and peripheral nerves) induced by MeHg were presented in common marmoset (Eto et al., 2001 (Eto et al., , 2002 but not in other type of monkeys such as rhesus monkeys (Shaw et al., 1975) .
The objective of this study is to use a shot-gun proteomic approach to study the effects of MeHg on protein expression and their consequent changes in biological functions through functional and pathway analysis in the cerebellum of common marmoset.
MATERIALS AND METHODS

Animals and Methylmercury Treatment
Experimental conditions concerning MeHg exposure in common marmoset was previously described (Yamamoto et al., 2012) . Briefly, 6 female common marmosets were administered MeHg chloride orally (1.5 mg Hg/kg body weight) or with a vehicle solution (containing 7.5 mM L-cysteine) daily for 2 weeks followed by 2 weeks without treatment (n ¼ 3 in each group). The marmosets were between 2-and 3-year-old and their body weights were between 250 and 330 g. The cerebellum regions were dissected after anesthesia and were immediately frozen in liquid nitrogen and stored at À80 C for proteomic analysis. All animal procedures were approved by the Animal Research Committee at the National Institute for Minamata disease, and all procedures conformed to the Guide for the Care and Use of Laboratory Animals by the Institute of Laboratory Animal Resources.
HPLC-ESI-MS/MS
In solution degistion and strong cationic exchange fractionation. Cerebellum samples dissected from marmoset treated with MeHg and vehicle were thawed, homogenized in 100 mM ammonia bicarbonate (ABC), 8 M Urea, 50 mM dithiothreitol (DTT), protease inhibitor, 1 mM ethylenediaminetetraacetic acid, and lysed with sonication. The samples were centrifuged at 16 000 g for 10 min and the protein concentration in the supernatant of each sample was determined by modified DC TM Protein Assay (Bio-Rad, Mississauga, Ontario, Canada). Protein extracts from each sample (100 lg) were precipitated by cold acetone overnight. A mixture of 8 M Urea with 50 mM ABC was used to reconstitute protein pellet. Reduction and alkylation were performed by addition of DTT to a final concentration of 20 mM at 56 C for 30 min followed by 60 mM iodoacetamide at room temperature for another 30 min. Samples were then digested with trypsin at a protein-enzyme ratio of 20:1 at 37 C overnight with gentle shaking. The digested peptides were acidified with formic acid (FA, 0.5% (v/v) C. One full MS scan from 300 to 1700 m/z was performed followed by data-dependent MS/MS scan of the 5 most intense ions. Dynamic exclusion was set to repeat count of 1 in 30 s, and exclusion duration of 90 s. For the full MS scan, the scan range was defined at m/z 400 with R ¼ 60 000 in Orbitrap analyzer, and the LTQ analyzer was applied for subsequent MS/MS analysis. To achieve an improved mass accuracy, a real time internal calibration was performed by locking the mass background ion at 445.120025 in the Orbitrap mass analyzer.
Data Analysis
The peak lists from raw files were generated with software MaxQuant (Version 1.3.0.5) and searched against SwissProt protein database of human (version 20 120 711), including commonly observed contaminants. The following criteria were applied: cysteine carbamidomethylation was set as a fixed modification; the methionine oxidation (þ15.99492 Da) and protein N-terminal acetylation were set as variable modification. Enzyme specificity was set to trypsin, not allowing for cleavage N-terminal to proline. Only 2 missing cleavages of trypsin were allowed. For MS/MS spectra, the precursor ion mass tolerances were 7 ppm, and fragment ion mass tolerance was set to 0.8 Da.
Razor and unique peptides were applied for quantitation. The false discovery rate was limited to 0.01 on both protein and peptide level. A minimum sequence length of 6 amino acids was required for peptide identification.
Protein identification and cellular component distribution. For protein identification, if the identified peptide sequence of 1 protein was equal to or contained in another protein's peptide set, these 2 proteins were grouped together by MaxQuant and reported as 1 protein group. For quantitation, a minimum of 2 spectra counts is needed. All the identifications from contaminants and reversed database were removed by Persues software (Version 1.3.0.4). Abundance ratios of proteins were based on the label-free quantitation of each group in the format of fold changes. The calculation of differentially expressed proteins was performed using Mann-Whitney U test with SPSS 16 (SPSS Inc., Chicago, Illinois). The differentially expressed proteins in each triplicate sample of the control and MeHg-treated groups were clustered into a heatmap and the consistency of samples within each of group was tested using Persues software. Cellular component attributes of all the identified proteins were classified using Ingenuity Pathway Analysis (IPA) software (Qiagen, Redwood, California). The cellular component distributions between all identified proteins and the differentially expressed proteins were compared. The distribution was expressed as the percentage of proteins associated with each cell component against the distributions of the total identified proteins. A Fisher's exact test was performed to test the difference between the distributions of the differentially expressed proteins and those of the total identified proteins.
Functional group mapping: GO enrichment/depletion analysis. The functional enrichment analysis of the 102 differentially changed proteins was conducted using Cytoscape ClueGO plug-in (Bindea et al., 2009 ) against the identified proteome, ie, the 1000 proteins. The functional classification was based on the Gene Oncology (GO) biological process. A 2-tailed hypergeometric statistic test was conducted to determine the most disturbed biological functions results from the differentially expressed proteins. Bonferroni method was used to correct the probability value, and the GO term restrictions (No. of gene/term ! 18 and % of term gene ! 15%) were applied to reduce the related term redundancy. Only GO terms with p value less than .05 were accepted and presented. Cytoscape CluePedia plug-in (Bindea et al., 2013) was used to visualize the known interactions (from STRING 9.0) between the GO terms and the associated proteins.
Two online web server software, Babelomics 4.2 (Medina et al., 2010) and Gorilla (Eden et al., 2009) , were used for GO cellular component enrichment analysis. A p value less than .05 was used as cut off.
In order to explore the potential regulated transcription factor of MeHg on ion transport, WebGestalt (WEB-based GEne SeT AnaLysis Toolkit) (Wang et al., 2013) was used to identify enrichment of miRNA targeted genes in the GO term of synaptic transmission.
Pathway enrichment analysis. Pathway enrichment analysis on the differentially expressed proteins was conducted using IPA and WebGestalt online sources. A list of 102 differentially expressed proteins in marmoset cerebellum was uploaded into the IPA database. One hundred proteins were identified and were eligible for generating Canonical signaling pathways. WebGestalt online source was also used for pathway analysis which provided the direct connection to biological pathways from Kyoto Encyclopedia of Gene and Genomes (KEGG). Hypergeometric test was used to calculate p values from the differentially expressed proteins against the identified 1000 proteome. Bonferroni method was applied to correct the p value for KEGG pathway analysis.
Western Blot Analysis
To validate the results from the proteomic analysis, 4 proteins, Disks large homolog 4 (DLG4), Sodium/calcium exchanger 1 (SLC8A1), Vesicular glutamate transporter 1 (SLC17A7), and T-complex protein 1 subunit zeta (CCT6A) were quantified using western blot. Protein extraction and concentration determination were the same as described in "In solution degistion and strong cationic exchange (SCX)". Protein samples (10-40 mg) were loaded and separated by 10%-12% Pre-cast gel (Bio-Rad).
Membranes were blocked for 1 h with 5% skim milk in Tris Buffered Saline þTween-20 (TBST), and incubated with various primary antibodies: DLG4 (1:350, ab18258), SLC17A7 (1:300, ab104898), and SLC8A1 (1:800, ab177952) (Abcam, Cambridge, Massachusetts), and CCT6A (1:200, sc-13896) (Santa Cruz Biotechnology Inc, Santa Cruz, California) at 4 C overnight.
After washing by TBST, membranes were incubated with Horseradish peroxidase-conjugated (HRP) secondary antibodies (Santa Cruz Biotechnology Inc), goat anti-rabbit IgG-HRP (1:12 000, sc-2004), or mouse anti-goat IgG-HRP (1:12 000, sc-2354) for 1 h at room temperature. The blots were stained by Clarity Western ECL Substrate (Bio-Rad), and target bands were visualized by using Chemidoc imaging system (Bio-Rad, Hercules, California). The target band was quantified by using image J software and the density of each band was normalized against GAPDH.
RESULTS
Protein Identification and Cellular Component Distribution
Proteomic analysis across the 6 cerebellum samples in control and the MeHg-treated groups resulted in the identification of 2563 proteins (Supplementary Table 1 ). Representative MS/MS spectra for 2 proteins DLG4 (P78352, Disks large homolog 4) and SLC17A7 (Q9P2U7, Vesicular glutamate transporter 1) are shown in Supplementary Figure 1 . Only proteins identified in all 6 samples in control and MeHg-treated mamoset cerebellum were included in our analysis, which resulted in 1000 proteins. A total of 102 proteins were found to be differentially expressed (86 decreased and 16 increased) in the MeHg-treated samples compared to the control (Supplementary Table 2 ). Figure 1A shows the abundance changes of differentially changed proteins between the control and MeHg-treated marmoset cerebellum samples. The triplicate samples in the control group and the the MeHg treatment group were clearly separated and a good consistency in the protein pattern was found within each group. Results of IPA gene ontology (GO) analysis of cellular component are shown in Figure 1B . The relative abundance of identified proteins was associated with various cellular components in the following descending order: cytoplasm (62%) > nucleus (16%) > plasma membrane (15%) > extracellular space (3%). The remaining 4% were associated with other organelles. The relative percentage of differentially expressed proteins distribution followed the order of cytoplasm (55%) > plasma membrane (27%) > nucleus (14%) > extracellular space (1%), and other organelles comprising 3%. There was a significant difference in organelle distribution between all the identified proteins and the differentially expressed proteins conducted by Fisher's exact test (p ¼ .046).
GO Analysis of Differentially Expressed Proteins in Cerebellum
The functional enrichment analysis results showed that 62 out of the 102 differentially expressed proteins were included in 24 significant GO terms (p < .05) ( Table 1 ). All the proteins associated with each of these 24 significant GO terms are shown in Supplementary Table 1. These significant GO terms were grouped into 3 groups and the key biological functions of these groups include: (1) carbohydrate derivative metabolic process and purine associated nucleotide metabolic process; (2) ion transport including vesicle-mediated transport and synaptic transmission; and (3) cell development as well as cell morphogenesis involved in neuron differentiation. Based on the protein similarity, the functional annotation network analysis clustered the significant GO terms into 3 different biological function groups (Figure 2) . It is shown visually that most of the differentially expressed proteins are associated with the carbohydrate derivative metabolic process, and purine and ribonucleotide metabolic processes. Core proteins such as DLG4, ATP2B2, and PLCB1 were found to be important in linking biological functions in carbohydrate derivative metabolic process, synaptic transmission, and cell development.
WebGestalt miRNA enrichment analysis showed the top 10 enriched miRNA targeting the 20 proteins included in the GO function term of synaptic transmission (Table 2) . MIR-19A and MIR-19B were the only significant miRNA that targeted 5 down-regulated proteins (NAPB, PLCB1, SYT1, BSN, ATP2B2, and NAPB) in the process of synaptic transmission ( Table 2) . Results of the GO cellular component enrichment analysis showed the differentially expressed proteins was significantly enriched in plasma membrane (46.1%), plasma membrane part (33.3%), membrane fraction (21.6%), and cell junction (15.7%) (Babelomics, Fisher's exact test, p < .05) (Figure 3) . Gorilla analysis also showed similar results that plasma membrane part (a child term under plasma membrane), excitatory synapse and Table 4) .
Pathway Analysis
Pathway analysis using IPA identified a total of 72 significant Canonical pathways. The top 16 Canonical pathways are shown in Figure 4 . Calcium transport I and calcium signaling were identified as the top and the 4th ranked pathways. Other important Canonical pathways included G protein signaling mediated by Tubby, remodelling of epithelial adherents, glutamatergic synapse, and gap junction (Figure 4) . Results of KEGG Pathway prediction using WebGestalt tool also showed the calcium signaling pathway as the only significant pathway that included 10 of the 102 differentially expressed proteins from MeHg treatment ( Supplementary Figs. 1 and 2 ).
Verification of Protein Expression Using an Alternative Method
Results of Western blot are shown in Figure 5 . These proteins were chosen as they are important in ion transport/synaptic transmission (SLC17A7), and calcium pathway (SLC8A1). DLG4 was the common protein involved in all the significant terms (carbohydrate derivative metabolic process, ion transportation, and cell development as well as cell morphogenesis in neuron differentiation) in MeHg-treated cerebellum. CCT6A, a protein that was not differentially expressed was also selected as a negative control for validation. There was a decrease expression of DLG4, and SLC17A7 and no significant change in CCT6A. These results agree with the MS results. While SLC8A1 was shown to be significantly decreased in the MS results, the western blot results showed a decrease trend but the result was not significant (Table 3) .
DISCUSSION
This is the first study using nonhuman primate as a model to investigate the global-proteome changes of MeHg neurotoxicity in the cerebellum of common marmoset. MeHg-treated marmoset monkeys showed slight akinesia and drunk-kind of motor dysfunction symptoms as described in Yamamoto et al., 2012. MeHg treatment increased the total concentrations of total mercury (Hg) in the cerebellum of the 3 MeHg-treated mamoset monkey to 23.5, 23.3, and 21.1 mg/g, respectively, compared to 0 mg/g in the control (Yamamoto et al., 2012) . These effects on motor functions are similar to those observed in humans exposed to high level of MeHg (Clarkson and Magos, 2006; Frumkin et al., 2001) suggesting that marmoset monkey is a good model for human MeHg toxicology study. In this study, we used human database searching for protein identification from MS/MS data. The main reasons are the similarity of neuroanatomy and behavior of common marmoset to humans, and the gene ontology for marmoset database was not fully built at the time this study was conducted. Moreover, our results of western blot using human originated antibodies were found to be applicable for marmoset brain samples. This also suggests the homology of genome sequence between the 2 species. MeHg treatment resulted in a decreased expression of 86 proteins and an increased expression of 16 proteins in the cerebellum. The numbers of differentially expressed proteins are similar to those reported by Zhang et al. (2010) studying effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on rat cerebellum. The cellular component distribution analysis showed that MeHg treatment did not just cause global nonspecific effects on all cellular components but had specific effects on the proteins in the cerebellar plasma membranes ( Figure 1B) . Results of the GO cellular component enrichment analysis also showed that MeHg-affected proteins mainly located in the plasma membrane (part), more specifically enriched in excitatory synapse, synaptic membrane and cell junction (Figure 3 and Supplementary Table 4) .
MeHg treatment was found to affect 3 main functions including carbohydrate derivative metabolic process, ion transport, and cell development (Table 1) . A total of 22 differentially expressed proteins were found involving in carbohydrate derivative metabolic process. All of these proteins were downregulated except for FBXO2, GNAQ, and VCP, indicating MeHg negatively affected carbohydrate metabolic process which was the main source of energy supply. Similar effects on carbohydrate metabolism were also reported in our earlier study in somatosensory cortex of rat with a low dose of MeHg treatment (Kong et al., 2013) .
Among all the ion transport functions, synaptic transmission was the most important function affected which is similar to the observation in MeHg exposed rat cerebellum (Radonjic et al., 2013) . Twenty differentially changed proteins were associated with synaptic transmission (Supplementary Table 3 ), and 4 of them (ATP2B2, CAMK2A, SLC17A7, and SYP) had previously been reported to be related to mercury toxicity (Fujimura et al., 2012; Huyck et al., 2014; Reddy et al., 1988; Yoshida et al., 2011) . Furthermore, the 20 proteins associated with synaptic transmission are mainly involved in the neurotransmitter regulation (BSN, DLG4, LGI1, NAPB, RAB11B, RAB3A, and SLC6A1), glutamate secretion and glutamate receptor signaling pathway (DLG4, PLCB1, SHANK1, SLC17A7, SYP, and SYT1), synapse calcium-dependent binding (ATP2B2, SNAP25, and SYT1), and others (AMPH, CNTNAP1, ITPKA, KCNJ10, and NCAN). The identification of enriched cellular component terms of excitatory synapse and synaptic membrane (Supplementary Table 4 ) also suggested that MeHg impact the neurotransmission by disruption proteins in excitatory synapse and synaptic membrane. These results are consistent with the previous studies that excitatory amino acid glutamate imbalance in neurons was one of the most important mechanisms in MeHg exposure (Farina et al., 2011; Yin et al., 2009) .
MeHg effects on brain structure and cell morphology have been extensively reported (Radonjic et al., 2013) . We also found significant effects on proteins associated with cell development, cell part morphogenesis, cell morphogenesis involved in differentiation, cell projection morphogenesis, and cell morphogenesis (group 3, Table 1 ). These results demonstrate the global effect of MeHg on cell development, neuronal morphology feature, and neuronal differentiation in the cerebellum.
Calcium homeostasis disruption has been well documented as one of the core mechanisms of MeHg toxicity (Limke et al., 2004; Yallapragada et al., 1996) . Calcium is involved in almost all types of the synapses plasticity regarding motor learning process in cerebellum (Lamont and Weber, 2012) . Our results showed calcium signaling pathway was the top pathway affected by MeHg as predicted by both IPA (Figure 4 ) and WebGestalt tools (Supplementary Figure 2) . Also, when a more broad-term examination using No. gene/term <5 with term fusion was applied for GO functional analysis, calcium ion transport, and cellular calcium ion homeostasis were observed in the 60 significant GO terms (Supplementary Table 3) . Moreover, a total of 10 (ATP2A2, ATP2B2, ATP2B1, CAMK2A, GNAS, GNAQ, ITPKA, PLCB1, SLC8A1, and SLC8A2) of the 102 changed proteins were mapped in KEGG calcium signaling pathway (Supplementary Figure 3) . Out of which, 5 proteins, ATP2B1/ATP2B2 (Burlando et al., 2004) , ATP2A2 (Gasso et al., 2001) , CAMK2A (Yoshida et al., 2011) , SLC8A1 (Furieri et al., 2011) , have been previously reported to relate to mercury toxicity. Therefore, these results confirmed that disruption of calcium pathway is a key mechanism for MeHg neurotoxicity. Among the 102 differentially changed proteins, DLG4, is a core protein that affected multiple functions as it was included in all of the 22 significant biological functional terms. This synaptic maker was down-regulated (about 3-folds) as shown by both LC-MS/MS and western blot results (Table 3) . DLG4 has been shown to play a major role in regulating the interaction between post-synaptic receptor particularly ionotropic glutamate receptor and associated signaling molecules (Nash et al., 2005; Porras et al., 2012) . Another key target of MeHg was MIR-19A/MIR-19B as they were shown to target the genes of 5 down-regulated proteins (NAPB, PLCB1, SYT1, BSN, ATP2B2, and NAPB) involved in synaptic transmission (Table 2) . MiR-19 family plays an important role in regulation of key genes in the neurodegenerative disease and variety of cancer process. For example, MIR-19 is a co-regulator to regulate the ataxin1, a gene that contribute to the progress of spinocerebellar ataxia type 1 (Lee et al., 2008) . The effects of MeHg on miRNA warrant further investigation.
In summary, using a primate model, we have shown the effects of MeHg on the dysfunction of motor function was mainly caused by disruption of carbohydrate derivative metabolic process, synaptic transmission process particularly calcium signaling pathway, and cell morphogenesis. We reported a total of 21 novel proteins affected by MeHg in synaptic transmission (Supplementary Table 3 ) and calciumassociated pathways (Supplementary Figure 3) . DLG4 and MIR-19A/MIR-19B were found as the key targets involved in synaptic transmission of MeHg neurotoxicity. Further investigation of their functions will contribute to the improved understanding of the pathogenesis of MeHg neurotoxicity in humans.
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